Concepedia
Statistics
Publications
56
Citations
4.4K
H-Index
34
Active since
1976
Affiliations
Novartis (Austria)(Current)
Forschungs- und Beratungsstelle Arbeitswelt
Novartis (Switzerland)
Novartis Institutes for BioMedical Research
University of Vienna
Josef G. Meingassner is an author at Novartis (Austria) specializing in medicine, dermatology, and immunology.
Top concepts
MedicineDermatologyImmunologyPharmacologyInflammationMicrobiologyImmunotherapyAutoimmune DiseaseAutoimmunityDrug Resistance
Publications per year
1976–2015
Comparison of human skin or epidermis models with human and animal skin in in-vitro percutaneous absorption
Fritz P. Schmook, Josef G. Meingassner, Andreas Billich · International Journal of Pharmaceutics · 2001 · 521 citations
Tissue Engineering, Skin Development, Engineering +12
Triggering the succinate receptor GPR91 on dendritic cells enhances immunity
Tina Rubic, Günther Lametschwandtner, Sandra Jost et al. · Nature Immunology · 2008 · 495 citations
Inflammation, Innate Immune System, Immunology +8
CCR7 is required for the in vivo function of CD4+ CD25+ regulatory T cells
Martin Schneider, Josef G. Meingassner, Martin Lipp et al. · The Journal of Experimental Medicine · 2007 · 311 citations · Full text
Antifungal activity of the allylamine derivative terbinafine in vitro
G Petrányi, Josef G. Meingassner, H Mieth · Antimicrobial Agents and Chemotherapy · 1987 · 241 citations
Medicinal Chemistry, Antifungal Agent, Bioorganic Chemistry +15
A novel anti-inflammatory drug, SDZ ASM 981, for the topical and oral treatment of skin diseases:<i>in vivo</i>pharmacology
Josef G. Meingassner, M. A. Grassberger, Hermann Fahrngruber et al. · British Journal of Dermatology · 1997 · 179 citations
1–5 of 56